101.508 articles found

Disease Duration Differentiates Freezing of Gait Response to Subthalamic and Nigral Stimulation for Parkinson's Disease in an Exploratory Multicenter Controlled Trial

Weiss D, Cebi I, Schütt M, Fischer I, Pavelka L, Kolber P, Pötter‐Nerger M, Hamel W, Kühn A, Hartmann C, Bötzel K, Köglsperger T, Barbe M, Kohl Z, Paschen S, Hobert M, Groppa S, Warnecke T, Claus I, Krüger R, Gharabaghi A.

Movement disorders clinical practice · 2026-10-12

Targeting the Gut to Modify Parkinson's Disease: From Mechanisms to Potential Therapeutics.

Tai YC, Lin CH.

J Mov Disord · 2026-10-12

DOI: 10.14802/jmd.26285PMID: 42860646

Candidate neurobiological pathways linking physical exercise to cognition in Parkinson's disease: a hypothesis-generating translational framework.

Byun K, Lee JY, Kim R.

J Mov Disord · 2026-10-12

DOI: 10.14802/jmd.26260PMID: 42860647

Disease Duration Differentiates Freezing of Gait Response to Subthalamic and Nigral Stimulation for Parkinson's Disease in an Exploratory Multicenter Controlled Trial.

Weiss D, Cebi I, Schütt M, Fischer I, Pavelka L, Kolber P, Pötter-Nerger M, Hamel W, Kühn AA, Hartmann CJ, Bötzel K, Köglsperger T, Barbe MT, Kohl Z, Paschen S, Hobert MA, Groppa S, Warnecke T, Claus I, Krüger R, Gharabaghi A, Multicenter STN+SNr Study Group.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70813PMID: 42860886

Caregiver Burden and Its Determinants After Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease: A Cross-Sectional Long-Term Follow-Up Study.

Margarido I, Pacheco C, Ramos J, Chamadoira C, Rito M, Oliveira A, Rosas MJ, Ferreira-Pinto MJ, Soares C.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70851PMID: 42860906

Persistent Therapeutic Burden after Device-Aided Therapy in Parkinson's Disease: Insights from Post-DAT MANAGE-PD Assessment.

Onder H, Gültekin M, Yavuz Z, Çıplaklıgil A, Comoglu S.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70861PMID: 42860929

Next-generation pharmacological strategies for Parkinson's disease: a systematic literature review of symptom management and disease modification.

Rajabalaya R, Mary AKN, Chellappan DK, Kunnath AP, Chellian J.

Neurol Sci · 2026-10-12

DOI: 10.1007/s10072-026-09466-7PMID: 42862400

Fixed-Sequence OFF-to-ON Differences in Low-Beta State Dynamics in Parkinson's Disease: A Paired Source-Space Resting-State EEG Study.

Wang H, Cheng Y, Wu G, Du X, Fan H, Yan J, Du G.

Brain Topogr · 2026-10-12

DOI: 10.1007/s10548-026-01253-zPMID: 42862408

Multiplexed impedimetric zinc oxide nanorods-modified aptasensor on carbon ink-inscribed paper electrodes for the specific and sensitive co-detection of Alzheimer's and Parkinson's disease.

Singh S, Ayaz A, Ansari O, Farooqi H, Narang J.

Biomed Microdevices · 2026-10-12

DOI: 10.1007/s10544-026-00855-5PMID: 42862409

The neuroinflammatory-metabolic loop in parkinsonian neurodegeneration.

Zahid K.

Inflammopharmacology · 2026-10-12

DOI: 10.1007/s10787-026-02401-4PMID: 42862514

The Impact of Neuropalliative Care on Caregivers of Individuals with Motor Neuron Disorders or Atypical Parkinsonism.

Mossa A, Price S, Paun O, Emezue C.

J Hosp Palliat Nurs · 2026-10-12

DOI: 10.1097/njh.0000000000001263PMID: 42862650

Immunosenescence as a modifiable driver of neurodegenerative diseases: Pathways and multidimensional emerging strategies for Alzheimer's and Parkinson's diseases.

Zhao J, Qu L, Guan H, Che H, Shi F, Yang Y.

Neurotherapeutics · 2026-10-12

DOI: 10.1016/j.neurot.2026.e01096PMID: 42863347